May
2023
Preclinical Contract CRO
Service Portfolio
×
In Vivo Pharmacology
- In-Vivo efficacy studies using appropriate animal disease models
- In-vivo biomarker assays such as ELISA, Histology, Immunohistochemistry, RT-PCR, WB etc..
- PK-PD Investigation
- Invasive and Non-invasive pharmacological read outs.
- Validation of various surgical models
- New and rare disease model development
- Dose, route and regime optimization studies
×
Cell Biology
- In vitro cell based efficacy screening using validated models in multiple therapeutic areas
- Comprehensive mechanistic elucidation for various class of test items
- In vitro cytotoxicity assays for organ toxicity
- Stem cells based in vitro studies
- Employment of well-established hallmark end point technologies such as Flow cytometry, ELISA, western blotting, PCR, Microscopy etc.
- Efficacy testing of products for claim substantiation
- Wide-ranging panels of Biomarkers in multiple disease and wellness areas
×
Toxicology
- Acute & Sub-acute toxicity studies
- Sub-chronic & Chronic toxicity studies
- Developmental & Reproductive Toxicity (DART) Studies
- Neurotoxicity studies
×
DMPK
- In vitro ADME studies
- Pharmacokinetic studies
- Tissue Distribution studies
- PK-PD studies
- Toxicokinetic studies
- Biomarker studies
- Bioanalysis
×
Formulation Development
- Formulation Development
- Lab/Pilot to Commercial Scale Process Development
- Lab/Pilot batch Manufacturing for study
- Product Characterization
- Shelf-Life Evaluation – Stability Study
- Product Docket Preparation and Technology Transfer
- Support to Commercial Scaleup and Process Validation
×
Analytical Chemistry
- Herbal Product Characterization
- Dose formulation analysis for preclinical studies
- 5 Batch analysis
- Phys-chem studies
- Residue analysis
×
Genetic Toxicology
- AMES Test (Salmonella typhimurium & E.coli)
- In vitro & In vivo Chromosomal Aberration Test
- In vitro & In vivo Micronucleus Test
- In vitro Cell Gene Mutation Test
Service Portfolio
×
In Vivo Pharmacology
- In-Vivo efficacy studies using appropriate animal disease models
- In-vivo biomarker assays such as ELISA, Histology, Immunohistochemistry, RT-PCR, WB etc..
- PK-PD Investigation
- Invasive and Non-invasive pharmacological read outs.
- Validation of various surgical models
- New and rare disease model development
- Dose, route and regime optimization studies
×
Cell Biology
- In vitro cell based efficacy screening using validated models in multiple therapeutic areas
- Comprehensive mechanistic elucidation for various class of test items
- In vitro cytotoxicity assays for organ toxicity
- Stem cells based in vitro studies
- Employment of well-established hallmark end point technologies such as Flow cytometry, ELISA, western blotting, PCR, Microscopy etc.
- Efficacy testing of products for claim substantiation
- Wide-ranging panels of Biomarkers in multiple disease and wellness areas
×
Toxicology
- Acute & Sub-acute toxicity studies
- Sub-chronic & Chronic toxicity studies
- Developmental & Reproductive Toxicity (DART) Studies
- Neurotoxicity studies
×
DMPK
- In vitro ADME studies
- Pharmacokinetic studies
- Tissue Distribution studies
- PK-PD studies
- Toxicokinetic studies
- Biomarker studies
- Bioanalysis
×
Formulation Development
- Formulation Development
- Lab/Pilot to Commercial Scale Process Development
- Lab/Pilot batch Manufacturing for study
- Product Characterization
- Shelf-Life Evaluation – Stability Study
- Product Docket Preparation and Technology Transfer
- Support to Commercial Scaleup and Process Validation
×
Analytical Chemistry
- Herbal Product Characterization
- Dose formulation analysis for preclinical studies
- 5 Batch analysis
- Phys-chem studies
- Residue analysis
×
Genetic Toxicology
- AMES Test (Salmonella typhimurium & E.coli)
- In vitro & In vivo Chromosomal Aberration Test
- In vitro & In vivo Micronucleus Test
- In vitro Cell Gene Mutation Test
Why choose Althea
We offer smart, innovative solutions allowing our customers to solve urgent needs based on sustainability, efficiency and cost-effectiveness. Our services are tailored to fit specific needs and optimize performances while using less resources. We work towards brining speed to the programs of our clients.
All studies conducted at our facilities in India are in accordance with the regulatory requirements of the EMA, US FDA, OECD, AAALAC. Our professionalism and exceptional customer oriented skills have given us a competitive edge and we have become the chosen outsourcing partner for a diverse set of customers.
Science and Technology
Our commitment to scientific research allows us to adapt to the latest technological shifts...
Partnership Driven
Althea’s unique position of being a partner driven company gives us the ability to harness...
Diversified Portfolio & Interests
Althea’s diversified interests make us an integrated healthcare and wellness company...
Innovative Healthcare Products
Althea has always worked towards adding innovation to definition of our name itself i.e. “HEALING”...
65000+
sq ft
Dedicated Lab Space
18000+
sq ft
State Of The Art Vivarium
105+
Instruments
Survelliance Monitoring
5000+
sq ft
Archival
Drug Development
Services
Our established scientific experience and customized, collaborative approach makes Althea the ideal partner for your company to achieve meaningful, high-quality, and fast results.
Together with Dabur Research Foundation, we provide scientific advice in selected therapeutic areas and a range of services easily adapted to your needs. With extensive experience in In Vitro, Ex-Vivo & In Vivo Pharmacology, Exploratory & GLP Toxicology & DMPK.
Visit our strategic partner website to know more : www.daburreseach.in
Our News & Events
- News
Event
23-25
China International Agrochemical & Crop Protection Equipment Exhibition
National Exhibition & Convention Center(Shanghai)
×
China International Agrochemical & Crop Protection Equipment Exhibition
We at Althea are happy to share our partner’s presence at the 23rd China International Agrochemical & Crop Protection Equipment Exhibition. If you would like to learn more about our services join us and chat with our team at our booth. Event details are as follows:
Date: May 23, 2023- May 25, 2023
Venue: National Exhibition and Convention Center (Shanghai)
Booth no.: 62P36
We, Dabur Research Foundation (DRF) are an Indian Contract Research Organization offering pre-clinical services in Discovery and Development to the pharmaceutical and agrochemical sectors. All DRF laboratories comply with Good Laboratory Practice (GLP), ISO & AAALAC.
Our services comprise of Exploratory & GLP Toxicology, Genotoxicology, Mutagenicity, Analytical (Physio chemical, Five batch, and DMPK), Residue analysis & REACH for a wide range of crop protection products such as Insecticides, Biocides, Herbicides, Fungicides, Nematicides, Repellents & Rodenticides.
News
10
Nov
2022
2022
The Science of Self-Care with Dr. Sheila Patel & Dr. Manu Jaggi
Want to learn more about self-care through...
News
24
Aug
2012
2012
Cosmetics testing kills 3.9 million animals
Inching towards animal free cosmetic testing
News
CMO
Asia Healthcare Excellence Awards
Asia Healthcare Excellence Awards
Emerging Brand of the Year-Nutrition
Althea DRF Lifesciences has won the award...
×
Emerging Brand of the Year-Nutrition
Althea DRF Lifesciences has won the award in the “Emerging Brand of the Year-Nutrition” category for the recent CMO Asia Healthcare Excellence Awards!
News
12
December
2019
2019
Dabur Research Foundation™ and Flowerkist Incorporated™ to Co-Develop and Launch a Wide...
Los Angeles
News
19
October
2022
2022
Dr. Deepak Chopra Aligns with Plant-Based Therapeutics Company ProVEDA to Highlight...
Miramar Beach
News
15
February
2023
2023
ProVEDA, a Plant-Based Therapeutics Company, Expands Line of Topical Solutions
Miramar Beach
News
15
March
2023
2023
Dr. Anu Singh featured in BioVoice News MAGAZINE
The Cover Story, “The Torchbearers of Indian...
News
12
October
2022
2022
Dabur Research Foundation - On it's Way to Becoming
The Most Valued Preclinical CRO of Country.
Our Partners
Our strong network of partners along with their specialized interests give us a unique positioning in the market, all leveraged through our own research and development infrastructure. We believe in creating an ecosystem of strategic alliances with our partners to help maximize their competitive advantage on mutually agreed terms toward a profitable business for all.
Accelerate your Preclinical Development
Althea along with its strategic partner Dabur Research Foundation guides and operates the technical and scientific needs of global biotech companies and pharmaceutical developers during the preclinical phase of research. We provide a solid foundation of laboratory & drug development services, disease models and expertise.
Start Project Services Overview
Do you want to enhance your research?
Questions about how our services can accelerate your research?
Reach out to one of our experts today and we can provide you with tailored advice on getting started.
0%